Please login to the form below

Not currently logged in
Email:
Password:

Immunocore appoints chief financial officer

Paul Fry brings leadership experience from GlaxoSmithKline

Oxford, UK-based Immunocore has appointed Paul Fry as its chief financial officer.

Fry has over two decades of senior management experience in the life sciences and telecommunications industries and joins the biotech from Vodafone, where he served as director of global finance operations.

Prior to this, Fry spent 25 years at GlaxoSmithKline, during which time he held a number of senior roles including head of global financial services and chief financial officer for the pharmaceutical company's Italian business.

In his most recent role there, Fry oversaw all the financial aspects of the exchange of GSK's oncology business for Novartis Vaccines.

Dr Eliot Forster, chief executive officer of Immunocore, said: “I am delighted that Immunocore has been able to recruit someone of the calibre of Paul Fry, who will provide leadership across our financial operations as we continue our mission to become a world leader in biotechnology.

“As Immunocore continues to grow we are continually looking for outstanding individuals such as Paul to complement our team. He joins at an exciting time for the company and we very much look forward to working with him.”

21st October 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....